Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
Read now
Daniel D. Reidpath, Nowrozy K. Jahan, Devi Mohan & Pascale Allotey. (2016) Single, community-based blood glucose readings may be a viable alternative for community surveillance of HbA1c and poor glycaemic control in people with known diabetes in resource-poor settings. Global Health Action 9:1.
Read now
Read now
S. Lane Slabaugh, Bradley H. Curtis, Gosia Clore, Haoda Fu & Dara P. Schuster. (2015) Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US. Journal of Medical Economics 18:2, pages 106-112.
Read now
Read now
Pnina Rotman-Pikielny, Rosane Ness-Abramof, Gideon Charach, Alexander Roitman, Rivka Zissin & Yair Levy. (2014) Efficacy and Safety of the Dietary Supplement DBCare® in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control. Journal of the American College of Nutrition 33:1, pages 55-62.
Read now
Read now
Michael Grabner, Yong Chen, Matthew Nguyen, Scott D Abbott & Ralph Quimbo. (2013) Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device. ClinicoEconomics and Outcomes Research 5, pages 471-479.
Read now
Read now
Robert J. Romanelli, Angela Leahy, Trevor Jukes, Xin Ye, Chunlin Qian & Denis Y. Ishisaka. (2013) Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network. Current Medical Research and Opinion 29:12, pages 1747-1756.
Read now
Read now
Michael Grabner, James Chu, Swetha Raparla, Ralph Quimbo, Steve Zhou & Joseph Conoshenti. (2013) Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial. Postgraduate Medicine 125:3, pages 204-213.
Read now
Read now
Stephen Brunton, Stephen Gough, Debbie Hicks, Jianping Weng, Etie Moghissi, Mark Peyrot, Doron Schneider, Petra Maria Schumm-Draeger, Christine Tobin & Anthony H. Barnett. (2011) A look into the future: improving diabetes care by 2015. Current Medical Research and Opinion 27:sup3, pages 65-72.
Read now
Read now
David S Cobden, Louis W Niessen, Frans FH Rutten & W Ken Redekop. (2010) Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach. Patient Preference and Adherence 4, pages 283-290.
Read now
Read now
Qiaoyi Zhang, Srini Rajagopalan, Panagiotis Mavros, Samuel S. Engel, Michael J. Davies, Donald Yin & Larry Radican. (2010) Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Current Medical Research and Opinion 26:7, pages 1697-1703.
Read now
Read now
Articles from other publishers (59)
Wendy A Davis, Emma Hamilton & Timothy M E Davis. (2023) Temporal Trends in Distal Symmetric Polyneuropathy in Type 2 Diabetes: The Fremantle Diabetes Study. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Wendy A. Davis & Timothy M. E. Davis. (2023) Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study. Cardiovascular Diabetology 22:1.
Crossref
Crossref
Beini Lyu, Yingying Sang, Elizabeth Selvin, Alex R. Chang, G. Caleb Alexander, Cheli Melzer Cohen, Josef Coresh, Varda Shalev, Gabriel Chodick, Avraham Karasik, Juan-Jesus Carrero, Edouard L. Fu, Yang Xu, Morgan E. Grams & Jung-Im Shin. (2022) Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel. Diabetes Care 45:12, pages 2926-2934.
Crossref
Crossref
Wendy A. Davis, Aron Chakera, Edward Gregg, Daniel McAullay & Timothy M. E. Davis. (2022) Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes Study. Journal of Clinical Medicine 11:3, pages 695.
Crossref
Crossref
桂花 林. (2022) Efficacy and Safety of Hydrogen Inhalation Therapy in Type 2 Diabetes Mellitus Patients Inadequately Controlled by Metformin Alone. Advances in Clinical Medicine 12:10, pages 9605-9612.
Crossref
Crossref
Sarah S Casagrande, Sarah E Lessem, Trevor J Orchard, Kai McKeever Bullard, Linda S Geiss, Sharon H Saydah, Andy Menke, Giuseppina Imperatore, Keith F Rust & Catherine C Cowie. (2020) Comparison of several survey-based algorithms to ascertain type 1 diabetes among US adults with self-reported diabetes. BMJ Open Diabetes Research & Care 8:2, pages e001917.
Crossref
Crossref
Wendy A Davis, Edward W Gregg & Timothy M E Davis. (2020) Temporal Trends in Cardiovascular Complications in People With or Without Type 2 Diabetes: The Fremantle Diabetes Study. The Journal of Clinical Endocrinology & Metabolism 105:7, pages e2471-e2482.
Crossref
Crossref
Xiaotong Yu, Lipeng Xu, Qiang Zhou, Shengping Wu, Jiaxing Tian, Chunli Piao, Hailong Guo, Jun Zhang, Liping Li, Shentao Wu, Meizhen Guo, Yuzhi Hong, Weirong Pu, Xiyan Zhao, Yang Liu, Bing Pang, Zhiping Peng, Song Wang, Fengmei Lian & Xiaolin Tong. (2018) The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical Trial. International Journal of Endocrinology 2018, pages 1-11.
Crossref
Crossref
Berhanu Alemayehu, Jinan Liu, Swapnil Rajpathak & Samuel S. Engel. (2017) Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas. Journal of Diabetes and its Complications 31:11, pages 1620-1623.
Crossref
Crossref
Gregg E. Dinse, Christine G. Parks, Clarice R. Weinberg, Helen C. S. Meier, Caroll A. Co, Edward K. L. Chan & Frederick W. Miller. (2017) Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004). PLOS ONE 12:10, pages e0185977.
Crossref
Crossref
Rick Ken Biethman, Cyril Pandarakalam, M. Nathalia Garcia, Sara Whitener & Charles F. Hildebolt. (2017) Screening for Diabetes in a Dental School Clinic to Assess Interprofessional Communication Between Physicians and Dental Students. Journal of Dental Education 81:9, pages 1062-1067.
Crossref
Crossref
John C. Pickup, Yves Reznik & Alex J. Sutton. (2017) Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials. Diabetes Care 40:5, pages 715-722.
Crossref
Crossref
Zohar Landau, Itamar Raz, Julio Wainstein, Yosefa Bar-Dayan & Avivit Cahn. (2017) The role of insulin pump therapy for type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews 33:1, pages e2822.
Crossref
Crossref
Yiting Wang, Janice M. S. Lopez, Susan C. Bolge, Vivienne J. Zhu & Paul E. Stang. (2016) Depression among people with type 2 diabetes mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005–2012. BMC Psychiatry 16:1.
Crossref
Crossref
Mohammed Ali Batais & Peter Schantter. (2016) Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia. Primary Care Diabetes 10:6, pages 415-424.
Crossref
Crossref
A. Nicolucci, K. Kovacs Burns, R. I. G. Holt, G. Lucisano, S. E. Skovlund, A. Kokoszka, M. Massi Benedetti & M. Peyrot. (2016)
Correlates of psychological outcomes in people with diabetes: results from the second Diabetes Attitudes, Wishes and Needs (DAWN2
™
) study
. Diabetic Medicine 33:9, pages 1194-1203.
Crossref
Crossref
Yiting WangSusan C. BolgeJanice M.S. LopezVivienne J. ZhuPaul E. Stang. (2016) Changes in Body Weight Among People With Type 2 Diabetes Mellitus in the United States, NHANES 2005-2012. The Diabetes Educator 42:3, pages 336-345.
Crossref
Crossref
Hervé Tchala Vignon Zomahoun, Jocelyne Moisan, Sophie Lauzier, Laurence Guillaumie, Jean-Pierre Grégoire & Line Guénette. (2016) Predicting Noninsulin Antidiabetic Drug Adherence Using a Theoretical Framework Based on the Theory of Planned Behavior in Adults With Type 2 Diabetes. Medicine 95:15, pages e2954.
Crossref
Crossref
Zhe He, Patrick Ryan, Julia Hoxha, Shuang Wang, Simona Carini, Ida Sim & Chunhua Weng. (2016) Multivariate analysis of the population representativeness of related clinical studies. Journal of Biomedical Informatics 60, pages 66-76.
Crossref
Crossref
Eva D.D. Tan, Wendy A. Davis & Timothy M.E. Davis. (2016) Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study. Journal of Diabetes 8:1, pages 139-147.
Crossref
Crossref
Soeren MattkeDan HanAsa WilksElizabeth Sloss. (2015) Medicare Home Visit Program Associated With Fewer Hospital And Nursing Home Admissions, Increased Office Visits. Health Affairs 34:12, pages 2138-2146.
Crossref
Crossref
H. Alzubaidi, K. Mc Mamara, C. Chapman, V. Stevenson & J. Marriott. (2015) Medicine-taking experiences and associated factors: comparison between Arabic-speaking and Caucasian English-speaking patients with Type 2 diabetes. Diabetic Medicine 32:12, pages 1625-1633.
Crossref
Crossref
Swapnil N. Rajpathak, Chunmay Fu, Kimberley Brodovicz, Samuel S. Engel & Pamela C. Heaton. (2015) Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes. Diabetes Research and Clinical Practice 109:3, pages 507-512.
Crossref
Crossref
Kate L. Lapane, Bill M. Jesdale, Catherine E. Dubé, Camilla B. Pimentel & Swapnil N. Rajpathak. (2015) Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 109:2, pages 411-419.
Crossref
Crossref
William T. Cefalu, Lawrence A. Leiter, Tjerk W.A. de Bruin, Ingrid Gause-Nilsson, Jennifer Sugg & Shamik J. Parikh. (2015) Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension. Diabetes Care 38:7, pages 1218-1227.
Crossref
Crossref
Hervé Tchala Vignon Zomahoun, Marijn de Bruin, Laurence Guillaumie, Jocelyne Moisan, Jean-Pierre Grégoire, Norma Pérez, Lydi-Anne Vézina-Im & Line Guénette. (2015) Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes: Systematic Review and Meta-Analysis. Value in Health 18:4, pages 530-540.
Crossref
Crossref
Yun Chen, Li Liu, Liqun Gu, Steven Babineaux, Hayley Colclough & Bradley Curtis. (2015) Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey. Diabetes Therapy 6:2, pages 197-211.
Crossref
Crossref
Elizabeth M. Webb, Paul Rheeder & Danie G. Van Zyl. (2015) Diabetes care and complications in primary care in the Tshwane district of South Africa. Primary Care Diabetes 9:2, pages 147-154.
Crossref
Crossref
Mendel Baba, Wendy A. Davis, Paul E. Norman & Timothy M.E. Davis. (2015) Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: The Fremantle Diabetes Study. Journal of Diabetes and its Complications 29:3, pages 356-361.
Crossref
Crossref
Stephan Matthaei, Keith Bowering, Katja Rohwedder, Anke Grohl & Shamik Parikh. (2015) Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial. Diabetes Care 38:3, pages 365-372.
Crossref
Crossref
Robert A Bailey, Yiting Wang, Vivienne Zhu & Marcia FT Rupnow. (2014) Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Research Notes 7:1.
Crossref
Crossref
John C. Pickup. (2014) Insulin pump therapy for type 2 diabetes mellitus. Nature Reviews Endocrinology 10:11, pages 647-649.
Crossref
Crossref
Kristina D. Chadwick, Anthony M. Fletcher, M. Cecilia Parrula, Susan Bonner-Weir, Raja S. Mangipudy, Evan Janovitz, Michael J. Graziano, Denis Roy & Timothy P. Reilly. (2014) Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of GLP-1–Based Therapies. Diabetes 63:4, pages 1303-1314.
Crossref
Crossref
Sau Nga Fu, Weng Yee Chin, Carlos King Ho Wong, Vincent Tok Fai Yeung, Ming Pong Yiu, Hoi Yee Tsui & Ka Hung Chan. (2013) Development and Validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for Primary Care Patients with Type 2 Diabetes. PLoS ONE 8:11, pages e78933.
Crossref
Crossref
Mark Tirmenstein, Thomas E. Dorr, Evan B. Janovitz, Deborah Hagan, Lynn M. Abell, Joelle M. Onorato, Jean M. Whaley, Michael J. Graziano & Timothy P. Reilly. (2013) Nonclinical Toxicology Assessments Support the Chronic Safety of Dapagliflozin, a First-in-Class Sodium-Glucose Cotransporter 2 Inhibitor. International Journal of Toxicology 32:5, pages 336-350.
Crossref
Crossref
E. Ferrannini, L. Seman, E. Seewaldt-Becker, S. Hantel, S. Pinnetti & H. J. Woerle. (2013) A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 15:8, pages 721-728.
Crossref
Crossref
Kate L. Lapane, Shibing Yang, Monique J. Brown, Rachel Jawahar, Caleb Pagliasotti & Swapnil Rajpathak. (2013) Sulfonylureas and Risk of Falls and Fractures: A Systematic Review. Drugs & Aging 30:7, pages 527-547.
Crossref
Crossref
R. Balena, I. E. Hensley, S. Miller & A. H. Barnett. (2012)
Combination therapy with
GLP
‐1 receptor agonists and basal insulin: a systematic review of the literature
. Diabetes, Obesity and Metabolism 15:6, pages 485-502.
Crossref
Crossref
M. J. Davies, J. J. Gagliardino, L. J. Gray, K. Khunti, V. Mohan & R. Hughes. (2013) Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabetic Medicine 30:5, pages 512-524.
Crossref
Crossref
D. S. H. Bell. (2012) Combine and conquer: advantages and disadvantages of fixed‐dose combination therapy. Diabetes, Obesity and Metabolism 15:4, pages 291-300.
Crossref
Crossref
Scott Drab. (2013) The Evolving Role of the Diabetes Educator. The American Journal of the Medical Sciences 345:4, pages 307-313.
Crossref
Crossref
Michael E. Farkouh, William E. Boden, Vera Bittner, Victoria Muratov, Pamela Hartigan, May Ogdie, Marnie Bertolet, Shiny Mathewkutty, Koon Teo, David J. Maron, Sanjum S. Sethi, Michael Domanski, Robert L. Frye & Valentin Fuster. (2013) Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials. Journal of the American College of Cardiology 61:15, pages 1607-1615.
Crossref
Crossref
Carles Zafon & Carmen Creus. (2011) A comparison on insulin regimen treatment of elderly (>70 years) and younger (<70 years) type 2 diabetic patients in actual clinical practice. Acta Diabetologica 50:1, pages 33-37.
Crossref
Crossref
Timothy M.E. Davis, Kerry Hunt, Daniel McAullay, Stephen A.P. Chubb, Brett A. Sillars, David G. Bruce & Wendy A. Davis. (2012) Continuing Disparities in Cardiovascular Risk Factors and Complications Between Aboriginal and Anglo-Celt Australians With Type 2 Diabetes. Diabetes Care 35:10, pages 2005-2011.
Crossref
Crossref
C. J. Bailey, N. Iqbal, C. T'joen & J. F. List. (2012) Dapagliflozin monotherapy in drug‐naïve patients with diabetes: a randomized‐controlled trial of low‐dose range. Diabetes, Obesity and Metabolism 14:10, pages 951-959.
Crossref
Crossref
Ronette R. Briefel & Margaret A. McDowell. 2012. Present Knowledge in Nutrition. Present Knowledge in Nutrition
1082
1109
.
K. Khunti, T. Damci, L. Meneghini, C. Y. Pan & J.‐F. Yale. (2012) Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes, Obesity and Metabolism 14:7, pages 654-661.
Crossref
Crossref
Nazia Rashid, Jeffrey S. McCombs & Elizabeth Schwartz. (2012) Effect of Exenatide, Pen Insulin, and Vial Insulin on Patient Outcomes: A Retrospective Database Analysis of Persistence and First-Year Costs in a Commercially Insured Population. Clinical Therapeutics 34:5, pages 1145-1158.
Crossref
Crossref
B. Balkau, S. Bouée, A. Avignon, B. Vergès, I. Chartier, E. Amelineau & S. Halimi. (2012) Type 2 diabetes treatment intensification in general practice in France in 2008–2009: the DIAttitude Study. Diabetes & Metabolism 38, pages S29-S35.
Crossref
Crossref
Lael Reinstatler, Yan Ping Qi, Rebecca S. Williamson, Joshua V. Garn & Godfrey P. OakleyJr.Jr.. (2012) Association of Biochemical B12 Deficiency With Metformin Therapy and Vitamin B12 Supplements. Diabetes Care 35:2, pages 327-333.
Crossref
Crossref
Jeffrey S. Kroin, Asokumar Buvanendran, Kenneth J. Tuman & James M. Kerns. (2012) Effect of Acute Versus Continuous Glycemic Control on Duration of Local Anesthetic Sciatic Nerve Block in Diabetic Rats. Regional Anesthesia and Pain Medicine 37:6, pages 595-600.
Crossref
Crossref
Stephen N. Davis, Wenhui Wei & Satish Garg. (2011) Clinical Impact of Initiating Insulin Glargine Therapy with Disposable Pen Versus Vial in Patients with Type 2 Diabetes Mellitus in a Managed Care Setting. Endocrine Practice 17:6, pages 845-852.
Crossref
Crossref
Erica B. Oberg, Ryan D. Bradley, Jason Allen & Megan A. McCrory. (2011) CAM: Naturopathic dietary interventions for patients with Type 2 diabetes. Complementary Therapies in Clinical Practice 17:3, pages 157-161.
Crossref
Crossref
Augusto F. Parcero, Thomas Yaeger & Robert S. Bienkowski. (2011) Frequency of Monitoring Hemoglobin A1C and Achieving Diabetes Control. Journal of Primary Care & Community Health 2:3, pages 205-208.
Crossref
Crossref
S. Wong, J. Lee, Y. Ko, M. F. Chong, C. K. Lam & W. E. Tang. (2011) Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabetic Medicine 28:2, pages 206-211.
Crossref
Crossref
Bernard Zinman. (2011) Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?. The American Journal of Medicine 124:1, pages S19-S34.
Crossref
Crossref
Wing‐Yee So & Juliana C. N. Chan. 2010. Textbook of Diabetes. Textbook of Diabetes
969
983
.
Clifford J Bailey, Jorge L Gross, Anne Pieters, Arnaud Bastien & James F List. (2010) Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. The Lancet 375:9733, pages 2223-2233.
Crossref
Crossref
. (2013) Treatment of diabetes suboptimal in US. PharmacoEconomics & Outcomes News 585:1, pages 8-8.
Crossref
Crossref